FedEx Establishes Direct Presence in Nigeria to Support Customers with International TradeRead more Open Society Foundations (OSF) Award $1.1 Million Grant to Afrobarometer to Spur Future GrowthRead more The annual Global Impact Conference 2022 brings together visionary business leaders to revolutionize educational systems and inspire collaborative actionRead more APO Group announces content partnership with Pan-African broadcaster VoxAfricaRead more MainOne, an Equinix Company’s MDXi Appolonia Achieves Tier III Constructed Facility certification (TCCF), Now Most Certified Data Center in GhanaRead more United Nations High Commissioner for Refugees (UNHCR) warns rising tide of hunger, insecurity, and underfunding worsening gender-based violence risksRead more The Royal Thai Embassy presents the cultures of Thailand at the Association of Southeast Asian Nations (ASEAN) Festival in KenyaRead more Climate change is the biggest global threat, young people in Africa and Europe tell European Investment Bank (EIB), Debating Africa and Debating EuropeRead more $2 million in prizes awarded at Conference of the Parties (COP27) to African youth-led businessesRead more Africa and Europe’s top business and public sector leaders gather to chart Africa’s economic rebirthRead more

Moderna Covid vaccine gets full US approval

show caption
Moderna's Covid-19 vaccine has received full FDA approval./AFP
Print Friendly and PDF

Feb 01, 2022 - 12:15 AM

WASHINGTON — The US Food and Drug Administration (FDA) announced Monday that it has granted full approval to Moderna’s Covid-19 “Spikevax” vaccine, which had previously received an emergency use authorization in the United States.

“The public can be assured that Spikevax meets the FDA’s high standards for safety, effectiveness and manufacturing quality required of any vaccine approved for use in the United States,” acting FDA commissioner Janet Woodcock said in a statement.

“The FDA’s approval of Spikevax is a significant step in the fight against the Covid-19 pandemic, marking the second vaccine approved to prevent Covid-19,” Woodcock said.

The full approval of the Moderna vaccine is for individuals aged 18 or older.

A Pfizer vaccine for individuals aged 16 or older received full FDA approval at the end of August.

Woodcock said she hoped FDA approval of the Moderna vaccine “may instill additional confidence in making the decision to get vaccinated.”

Moderna CEO Stephane Bancel called the FDA move a “momentous milestone” for the company.

“Our Covid-19 vaccine has been administered to hundreds of millions of people around the world, protecting people from Covid-19 infection, hospitalization and death,” Bancel said in a statement.

The Moderna vaccine received an emergency use authorization in December 2020.

The full approval from the FDA concerns the first two doses of the Moderna vaccine. A booster dose remains under an emergency use authorization.

The FDA said clinical trials to determine the effectiveness of Spikevax included 14,287 vaccine recipients and 14,164 placebo recipients.

The most common side effects by clinical trial participants were pain at the injection site, fatigue, headaches, muscle or joint pain, chills, nausea or vomiting and swollen lymph nodes, the FDA said.

It said there was an increased risk in men aged 18 to 24 of myocarditis — inflammation of the heart muscle — and pericarditis — inflammation of tissue surrounding the heart — following vaccination with the second dose.

But, the FDA said, it has determined that the “benefits of the vaccine outweigh the risk of myocarditis and pericarditis in individuals 18 years of age and older.”

MAORANDCITIES.COM uses both Facebook and Disqus comment systems to make it easier for you to contribute. We encourage all readers to share their views on our articles and blog posts. All comments should be relevant to the topic. By posting, you agree to our Privacy Policy. We are committed to maintaining a lively but civil forum for discussion, so we ask you to avoid personal attacks, name-calling, foul language or other inappropriate behavior. Please keep your comments relevant and respectful. By leaving the ‘Post to Facebook’ box selected – when using Facebook comment system – your comment will be published to your Facebook profile in addition to the space below. If you encounter a comment that is abusive, click the “X” in the upper right corner of the Facebook comment box to report spam or abuse. You can also email us.